FRESH-PEF5682-en
Influence of the Glycemic and Ponderal Status on Tissues Gene Expression (Biological Tissue Collection)
ABOS (Atlas Biologique de l'Obésité Sévère)
| Name | Country code |
|---|---|
| France | fr |
['Clinical data','Biological data','Participant-reported health data']
Individuals
| Topic | Vocabulary |
|---|---|
| Endocrinology | health theme |
| Behavioral determinants | health determinant |
| Behavioral determinants: Eating habits | health determinant |
| Biological determinants: Genetic predisposition | health determinant |
| Biological determinants | health determinant |
{"level_sex_clusion_I":[{"value":"Male","concept":{"vocab":"MeSH","vocabURI":"D008297"}},{"value":"Female","concept":{"vocab":"MeSH","vocabURI":"D005260"}}],"level_age_clusion_I":[{"value":"Child (6 to 12 years)","concept":{"vocab":"MeSH","vocabURI":"D002648"}},{"value":"Adolescent (13 to 18 years)","concept":{"vocab":"MeSH","vocabURI":"D000293"}},{"value":"Young Adult (19 to 24 years)","concept":{"vocab":"MeSH","vocabURI":"D055815"}},{"value":"Adult (25 to 44 years)","concept":{"vocab":"MeSH","vocabURI":"D000328"}},{"value":"Middle Aged (45 to 64 years)","concept":{"vocab":"MeSH","vocabURI":"D008875"}}],"level_type_clusion_I":"General population","level_type_clusion_other":"","clusion_I":"• Age between 18 and 65 years. • Indication of abdominal surgery requiring laparotomy or coelioscopy for obesity surgery, a cholecystectomy, or a parietal surgery. • phenotype corresponding to one of the following four cases 1. BMI greater than or equal to 35 kg/m2 and diabetes defined by glucose greater or equal to 7 mmol/l fasting and/or greater than or equal to 11.1 mmol/l, 120 min after glucose intake (OGTT). 2. BMI greater than or equal to 35 kg/m2 and IGT defined by a higher than 6 mmol/l and less than 7 mmol/l fasting blood glucose, and/or greater than 7.8 mmol/l and less than 11.1 mmol/l, 120 min after glucose intake (OGTT). 3. BMI greater than or equal to 35 kg/m2 and with normal glucose tolerance defined by a blood glucose of less than or equal to 6 mmol/l and/or less than or equal to 7.8 mmol/l, 120 min after glucose intake (OGTT). 4. BMI inferior to 27 kg/m2 and with normal glucose tolerance defined by a blood glucose of less than or equal to 6 mmol/l and/or less than or equal to 7.8 mmol/l, 120 min after glucose intake (OGTT) (control group). 5. BMI between 27 and 35 27 kg/m2 and with normal glucose tolerance defined by a blood glucose less than or equal to 6 mmol/l and/or less than or equal to 7.8 mmol/l, 120 min after glucose intake (OGTT) (control group).","clusion_E":""}
| Name |
|---|
| François;PATTOU |
| Name | Role |
|---|---|
| CENTRE HOSPITALIER UNIVERSITAIRE DE LILLE (CHU) | sponsor |
| Name |
|---|
| CENTRE HOSPITALIER UNIVERSITAIRE DE LILLE (CHU) |
| VAIOMER |
| Agency name |
|---|
| CPP |
['Through organizations (health services or institutions, schools, businesses, etc.)']
['{"concept":{"vocabURI":"Other","vocab":"CESSDA"},"value":"Other"}']
Access on specific project only
Observational Study
| Start | End |
|---|---|
| 2006-01-01 | 3000-01-01 |
['monitoring promoteur']
Contact the principal investigator
{"value":"Restricted access","extLink":[{"title":"COAR","uri":"http://purl.org/coar/access_right/c_16ec"}]}
| Name | |
|---|---|
| François;PATTOU | fpattou@univ-lille2.fr |